Arlington-backed AVS Bio acquires UK bioreagent supplier Biorbyt in add-on deal
Wednesday, September 23, 2026 · first reported by PE Hub
Arlington Capital Partners-backed AVS Bio acquires Cambridge-based bioreagent supplier Biorbyt (founded 2011, 1M+ SKU catalog) as add-on consolidation.
- Asset class
- Private equity
- Geography
- North America, Europe
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 sourceMore in Deals
From the same day- Curium Resets FTC Clock On $8B Lantheus Take-Private DealLaw360
- CD&R and Warburg Pincus emerge as leading bidders for Canaccord WealthPrivate Equity Wire
- Bain Capital Agreed to Buy SOLitude Lake Management from Rentokil for $230 MillionHedgeCo Insights
- GHK Capital-backed WSB acquires engineering firm PolyPE Hub
- Goldman Sachs emerges as lead bidder for $37bn credit manager Palmer SquarePrivate Equity Wire
- Argosy’s Command Medical Products Acquires IMATSPrivate Equity Professional